BRISTOL-MYERS SQUIBB CO (1BMY.MI) Fundamental Analysis & Valuation

BIT:1BMY • US1101221083

52.8 EUR
-0.64 (-1.2%)
Last: Mar 5, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership

This 1BMY.MI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

5

Taking everything into account, 1BMY scores 5 out of 10 in our fundamental rating. 1BMY was compared to 54 industry peers in the Pharmaceuticals industry. While 1BMY has a great profitability rating, there are some minor concerns on its financial health. 1BMY is valued quite cheap, but it does not seem to be growing. 1BMY also has an excellent dividend rating. These ratings would make 1BMY suitable for value and dividend investing!


Dividend Valuation Growth Profitability Health

7

1. 1BMY.MI Profitability Analysis

1.1 Basic Checks

  • In the past year 1BMY was profitable.
  • 1BMY had a positive operating cash flow in the past year.
  • 1BMY had positive earnings in 4 of the past 5 years.
  • 1BMY had a positive operating cash flow in each of the past 5 years.
1BMY.MI Yearly Net Income VS EBIT VS OCF VS FCF1BMY.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5B -5B 10B 15B

1.2 Ratios

  • With a Return On Assets value of 7.83%, 1BMY perfoms like the industry average, outperforming 55.56% of the companies in the same industry.
  • Looking at the Return On Equity, with a value of 38.19%, 1BMY belongs to the top of the industry, outperforming 87.04% of the companies in the same industry.
  • With a decent Return On Invested Capital value of 19.52%, 1BMY is doing good in the industry, outperforming 77.78% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for 1BMY is in line with the industry average of 14.78%.
  • The 3 year average ROIC (14.47%) for 1BMY is below the current ROIC(19.52%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 7.83%
ROE 38.19%
ROIC 19.52%
ROA(3y)2.2%
ROA(5y)3.91%
ROE(3y)3.56%
ROE(5y)10.1%
ROIC(3y)14.47%
ROIC(5y)12.91%
1BMY.MI Yearly ROA, ROE, ROIC1BMY.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 -40

1.3 Margins

  • 1BMY has a Profit Margin of 14.64%. This is comparable to the rest of the industry: 1BMY outperforms 57.41% of its industry peers.
  • 1BMY's Profit Margin has improved in the last couple of years.
  • 1BMY's Operating Margin of 35.82% is amongst the best of the industry. 1BMY outperforms 85.19% of its industry peers.
  • In the last couple of years the Operating Margin of 1BMY has grown nicely.
  • With a Gross Margin value of 72.63%, 1BMY perfoms like the industry average, outperforming 59.26% of the companies in the same industry.
  • In the last couple of years the Gross Margin of 1BMY has remained more or less at the same level.
Industry RankSector Rank
OM 35.82%
PM (TTM) 14.64%
GM 72.63%
OM growth 3Y13.23%
OM growth 5Y20.59%
PM growth 3Y2.21%
PM growth 5YN/A
GM growth 3Y-2.43%
GM growth 5Y-0.33%
1BMY.MI Yearly Profit, Operating, Gross Margins1BMY.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. 1BMY.MI Health Analysis

2.1 Basic Checks

  • 1BMY has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
  • 1BMY has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, 1BMY has less shares outstanding
  • 1BMY has a better debt/assets ratio than last year.
1BMY.MI Yearly Shares Outstanding1BMY.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B
1BMY.MI Yearly Total Debt VS Total Assets1BMY.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B 80B 100B

2.2 Solvency

  • An Altman-Z score of 2.55 indicates that 1BMY is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • The Altman-Z score of 1BMY (2.55) is comparable to the rest of the industry.
  • The Debt to FCF ratio of 1BMY is 3.51, which is a good value as it means it would take 1BMY, 3.51 years of fcf income to pay off all of its debts.
  • 1BMY has a Debt to FCF ratio of 3.51. This is in the better half of the industry: 1BMY outperforms 64.81% of its industry peers.
  • A Debt/Equity ratio of 2.33 is on the high side and indicates that 1BMY has dependencies on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 2.33, 1BMY is doing worse than 81.48% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 2.33
Debt/FCF 3.51
Altman-Z 2.55
ROIC/WACC2.23
WACC8.74%
1BMY.MI Yearly LT Debt VS Equity VS FCF1BMY.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B 40B 50B

2.3 Liquidity

  • A Current Ratio of 1.26 indicates that 1BMY should not have too much problems paying its short term obligations.
  • The Current ratio of 1BMY (1.26) is comparable to the rest of the industry.
  • A Quick Ratio of 1.14 indicates that 1BMY should not have too much problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 1.14, 1BMY is in the better half of the industry, outperforming 62.96% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.26
Quick Ratio 1.14
1BMY.MI Yearly Current Assets VS Current Liabilites1BMY.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. 1BMY.MI Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 439.47% over the past year.
  • 1BMY shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -0.92% yearly.
  • Looking at the last year, 1BMY shows a decrease in Revenue. The Revenue has decreased by -0.22% in the last year.
  • Measured over the past years, 1BMY shows a small growth in Revenue. The Revenue has been growing by 2.54% on average per year.
EPS 1Y (TTM)439.47%
EPS 3Y-7.62%
EPS 5Y-0.92%
EPS Q2Q%-24.55%
Revenue 1Y (TTM)-0.22%
Revenue growth 3Y1.45%
Revenue growth 5Y2.54%
Sales Q2Q%1.3%

3.2 Future

  • Based on estimates for the next years, 1BMY will show a decrease in Earnings Per Share. The EPS will decrease by -4.54% on average per year.
  • 1BMY is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -5.62% yearly.
EPS Next Y-1.05%
EPS Next 2Y-1.88%
EPS Next 3Y-3.16%
EPS Next 5Y-4.54%
Revenue Next Year-1.88%
Revenue Next 2Y-2.07%
Revenue Next 3Y-5.43%
Revenue Next 5Y-5.62%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
1BMY.MI Yearly Revenue VS Estimates1BMY.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 10B 20B 30B 40B
1BMY.MI Yearly EPS VS Estimates1BMY.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6

More info and screens

Find the best growth stocksShow best growing peers

7

4. 1BMY.MI Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 9.92, the valuation of 1BMY can be described as reasonable.
  • 83.33% of the companies in the same industry are more expensive than 1BMY, based on the Price/Earnings ratio.
  • 1BMY is valuated cheaply when we compare the Price/Earnings ratio to 26.46, which is the current average of the S&P500 Index.
  • A Price/Forward Earnings ratio of 10.03 indicates a reasonable valuation of 1BMY.
  • 83.33% of the companies in the same industry are more expensive than 1BMY, based on the Price/Forward Earnings ratio.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 24.65, 1BMY is valued rather cheaply.
Industry RankSector Rank
PE 9.92
Fwd PE 10.03
1BMY.MI Price Earnings VS Forward Price Earnings1BMY.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, 1BMY is valued cheaply inside the industry as 83.33% of the companies are valued more expensively.
  • 88.89% of the companies in the same industry are more expensive than 1BMY, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 9.67
EV/EBITDA 7.42
1BMY.MI Per share data1BMY.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 15 20

4.3 Compensation for Growth

  • 1BMY has a very decent profitability rating, which may justify a higher PE ratio.
  • A cheap valuation may be justified as 1BMY's earnings are expected to decrease with -3.16% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-1.88%
EPS Next 3Y-3.16%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

7

5. 1BMY.MI Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 4.12%, 1BMY is a good candidate for dividend investing.
  • 1BMY's Dividend Yield is rather good when compared to the industry average which is at 1.91. 1BMY pays more dividend than 81.48% of the companies in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.82, 1BMY pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.12%

5.2 History

  • On average, the dividend of 1BMY grows each year by 6.51%, which is quite nice.
Dividend Growth(5Y)6.51%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

  • 71.52% of the earnings are spent on dividend by 1BMY. This is not a sustainable payout ratio.
  • The Dividend Rate of 1BMY has been growing, while earnings will be declining. This means the dividend growth is most likely not sustainable.
DP71.52%
EPS Next 2Y-1.88%
EPS Next 3Y-3.16%
1BMY.MI Yearly Income VS Free CF VS Dividend1BMY.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5B -5B 10B 15B
1BMY.MI Dividend Payout.1BMY.MI Dividend Payout, showing the Payout Ratio.1BMY.MI Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

1BMY.MI Fundamentals: All Metrics, Ratios and Statistics

BRISTOL-MYERS SQUIBB CO

BIT:1BMY (3/5/2026, 7:00:00 PM)

52.8

-0.64 (-1.2%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)02-05
Earnings (Next)04-30
Inst Owners81.87%
Inst Owner ChangeN/A
Ins Owners0.02%
Ins Owner ChangeN/A
Market Cap107.49B
Revenue(TTM)48.19B
Net Income(TTM)7.05B
Analysts70.59
Price Target52.72 (-0.15%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.12%
Yearly Dividend2.13
Dividend Growth(5Y)6.51%
DP71.52%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)9.39%
Min EPS beat(2)6.92%
Max EPS beat(2)11.85%
EPS beat(4)4
Avg EPS beat(4)18.29%
Min EPS beat(4)6.92%
Max EPS beat(4)35.04%
EPS beat(8)8
Avg EPS beat(8)16.75%
EPS beat(12)11
Avg EPS beat(12)12.26%
EPS beat(16)15
Avg EPS beat(16)10.82%
Revenue beat(2)2
Avg Revenue beat(2)1.61%
Min Revenue beat(2)0.79%
Max Revenue beat(2)2.43%
Revenue beat(4)4
Avg Revenue beat(4)3.42%
Min Revenue beat(4)0.79%
Max Revenue beat(4)6.79%
Revenue beat(8)8
Avg Revenue beat(8)3.86%
Revenue beat(12)9
Avg Revenue beat(12)1.94%
Revenue beat(16)12
Avg Revenue beat(16)1.77%
PT rev (1m)8.14%
PT rev (3m)16.41%
EPS NQ rev (1m)1.09%
EPS NQ rev (3m)-4.14%
EPS NY rev (1m)0%
EPS NY rev (3m)-0.15%
Revenue NQ rev (1m)3.32%
Revenue NQ rev (3m)2.22%
Revenue NY rev (1m)6.63%
Revenue NY rev (3m)6.92%
Valuation
Industry RankSector Rank
PE 9.92
Fwd PE 10.03
P/S 2.58
P/FCF 9.67
P/OCF 8.78
P/B 6.73
P/tB N/A
EV/EBITDA 7.42
EPS(TTM)5.32
EY10.08%
EPS(NY)5.26
Fwd EY9.97%
FCF(TTM)5.46
FCFY10.34%
OCF(TTM)6.01
OCFY11.39%
SpS20.48
BVpS7.85
TBVpS-9.51
PEG (NY)N/A
PEG (5Y)N/A
Graham Number30.65
Profitability
Industry RankSector Rank
ROA 7.83%
ROE 38.19%
ROCE 25.91%
ROIC 19.52%
ROICexc 23.22%
ROICexgc 84.94%
OM 35.82%
PM (TTM) 14.64%
GM 72.63%
FCFM 26.65%
ROA(3y)2.2%
ROA(5y)3.91%
ROE(3y)3.56%
ROE(5y)10.1%
ROIC(3y)14.47%
ROIC(5y)12.91%
ROICexc(3y)17.24%
ROICexc(5y)15.38%
ROICexgc(3y)72.12%
ROICexgc(5y)85.46%
ROCE(3y)19.19%
ROCE(5y)17.14%
ROICexgc growth 3Y-3.78%
ROICexgc growth 5Y13.73%
ROICexc growth 3Y21.19%
ROICexc growth 5Y33.96%
OM growth 3Y13.23%
OM growth 5Y20.59%
PM growth 3Y2.21%
PM growth 5YN/A
GM growth 3Y-2.43%
GM growth 5Y-0.33%
F-Score7
Asset Turnover0.54
Health
Industry RankSector Rank
Debt/Equity 2.33
Debt/FCF 3.51
Debt/EBITDA 2.03
Cap/Depr 32.69%
Cap/Sales 2.72%
Interest Coverage 8.22
Cash Conversion 66.54%
Profit Quality 182.1%
Current Ratio 1.26
Quick Ratio 1.14
Altman-Z 2.55
F-Score7
WACC8.74%
ROIC/WACC2.23
Cap/Depr(3y)19.36%
Cap/Depr(5y)15.61%
Cap/Sales(3y)2.66%
Cap/Sales(5y)2.5%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)439.47%
EPS 3Y-7.62%
EPS 5Y-0.92%
EPS Q2Q%-24.55%
EPS Next Y-1.05%
EPS Next 2Y-1.88%
EPS Next 3Y-3.16%
EPS Next 5Y-4.54%
Revenue 1Y (TTM)-0.22%
Revenue growth 3Y1.45%
Revenue growth 5Y2.54%
Sales Q2Q%1.3%
Revenue Next Year-1.88%
Revenue Next 2Y-2.07%
Revenue Next 3Y-5.43%
Revenue Next 5Y-5.62%
EBIT growth 1Y49.54%
EBIT growth 3Y14.87%
EBIT growth 5Y23.65%
EBIT Next Year23.75%
EBIT Next 3Y2.42%
EBIT Next 5Y-1.78%
FCF growth 1Y-7.87%
FCF growth 3Y2.44%
FCF growth 5Y-0.69%
OCF growth 1Y-6.81%
OCF growth 3Y2.71%
OCF growth 5Y0.15%

BRISTOL-MYERS SQUIBB CO / 1BMY.MI FAQ

Can you provide the ChartMill fundamental rating for BRISTOL-MYERS SQUIBB CO?

ChartMill assigns a fundamental rating of 5 / 10 to 1BMY.MI.


Can you provide the valuation status for BRISTOL-MYERS SQUIBB CO?

ChartMill assigns a valuation rating of 7 / 10 to BRISTOL-MYERS SQUIBB CO (1BMY.MI). This can be considered as Undervalued.


Can you provide the profitability details for BRISTOL-MYERS SQUIBB CO?

BRISTOL-MYERS SQUIBB CO (1BMY.MI) has a profitability rating of 7 / 10.


Can you provide the financial health for 1BMY stock?

The financial health rating of BRISTOL-MYERS SQUIBB CO (1BMY.MI) is 5 / 10.


Is the dividend of BRISTOL-MYERS SQUIBB CO sustainable?

The dividend rating of BRISTOL-MYERS SQUIBB CO (1BMY.MI) is 7 / 10 and the dividend payout ratio is 71.52%.